Table 1.
Baseline demographics, as well as clinical and radiological characteristics in patients with and without intraventricular hemorrhage growth (IVH growth), in patients with intracerebral hemorrhage.
| Baseline Characteristics | All (n = 735) |
|---|---|
| Age [years], median (IQR) | 73 (62–80) |
| Female, n (%) | 410 (56.9) |
| Systolic RR [mmHg], median (IQR) | 165 (145–195) |
| Hypertension, n (%) | 581 (80.7) |
| Diabetes mellitus, n (%) | 121 (16.6) |
| Anticoagulation Treatment, n (%) | 201 (27.9) |
| Antiplatelet Treatment, n (%) | 324 (45.0) |
| GCS admission, median (IQR) | 13 (9–15) |
| Δ symptom onset to imaging [h], median (IQR) | 6.23 (1.65–17.55) |
| Craniotomy, n (%) | 116 (16.11) |
| Hemorrhage Characteristics | |
| ICH Volume on admission [mL], mean (SD) | 44.56 (5.99) |
| ICH Volume on follow-up [mL], mean (SD) | 60.86 (16.42) |
| Intraventricular hemorrhage on admission, n (%) | 327 (45.42) |
| Intraventricular hemorrhage on follow-up, n (%) | 363 (50.4) |
| HE [>6 mL; >33%], n (%) | 150 (20.8) |
| revised HE [HE; IVH growth], n (%) | 271 (37.7) |
| Location characteristics | |
| Supratentorial, n (%) | 615 (85.4) |
| Lobar, n (%) | 309 (43) |
| Basal ganglia, n (%) | 306 (42.6) |
| Thalamic, n (%) | 36 (5.7) |
| Brainstem/pons, n (%) | 69 (9.6) |
| Cerebellar, n (%) | 35 (4.9) |
| Clinical Outcome | |
| mRS 0–3, n (%) | 190 (26.39) |
| mRS 4–6, n (%) | 530 (73.61) |
| mRS 6 (mortality), n (%) | 188 (26.10) |
Legend: HE, hematoma expansion; ICH, intracerebral hemorrhage; IQR, interquartile range; IVH, intraventricular hemorrhage; GCS, Glasgow Come Scale; mRS, modified Rankin Scale; RR, arterial blood pressure.